Metsä Board has submitted the EIA report for the Kaskinen paperboard mill to the ELY Centre of South Ostrobothnia

Metsä Board, part of Metsä Group, has submitted the EIA report for the Kaskinen paperboard mill in accordance with the Environmental Impact Assessment Procedure Act to the South Ostrobothnia Regional Economic, Transport and Environment Centre (ELY Centre). The report is open for public comment and opinion from 25.05.2023 to 21.07.2023.

The ELY Centre will make the EIA report prepared by Metsä Board available to the public for 60 days for comments and opinions starting on 25 May. During this time, the assessment report will be available on the internet at www.ymparisto.fi/kaskinenkartonkitehdasYVA and at the following locations:
• Kaskinen Town Hall and City Library
• Närpiö Town Hall and Main Library
• Kristiinankaupunki Town Hall and Library

The EIA procedure addresses the environmental impact of Metsä Board’s planned paperboard mill on the existing mill site in Kaskinen. The EIA is a two-stage procedure. In the first stage, the project developer draws up an assessment programme and in the second stage, the evaluations are carried out and an assessment report is prepared.

The results of the impact assessment will be considered in the ongoing planning and decision-making process. The EIA process does not make decisions on the project but aims to provide information to support decision-making and to increase public access to information and influence.

The next public meeting on the EIA process will be held on Monday 19 June at 17.00–20.00 at Kaskinen Sports Hall, Sulkukatu 11, 64260 Kaskinen. It will also be possible to participate via Teams. The link can be found at www.ymparisto.fi/kaskinenkartonkitehdasYVA before the public event.

Metsä Board started pre-engineering for the new paperboard mill in Kaskinen in autumn 2022, which is based on fossil free production and world-class resource, production and environmental efficiency. Metsä Board estimates that a potential investment decision can be made in 2024 at the earliest.
more at: https://www.metsagroup.com/metsaboard/news-and-publications/news/2023/metsa-board-has-submitted-the-eia-report-for-the-kaskinen-paperboard-mill-to-the-ely-centre-of-south-ostrobothnia/

Related Posts

Berry and Glatfelter Announce Regulatory Milestone in Proposed Transaction for Spin-Off and Merger of Berry’s Health, Hygiene and Specialties Global Nonwovens and Films Business with Glatfelter

Berry Global Group, Inc. and Glatfelter Corporation announced the achievement of a regulatory milestone in the proposed transaction involving the combination of a majority of Berry’s Health, Hygiene and Specialties segment to include its Global Nonwovens and Films business (“HHNF”) with Glatfelter, with the expiration of the required waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act. As previously announced on February 7, 2024, Berry and Glatfelter entered into a definitive agreement under which Berry will spin-off and merge its HHNF business with Glatfelter in a Reverse Morris Trust transaction. The transaction will create a leading, publicly-traded company in the specialty materials industry. The transaction is expected to close in the second half of calendar 2024 and is subject to approval by Glatfelter shareholders and completion of customary closing conditions.

New research report says systemic change in food packaging recycling only possible through public-private partnerships to drive innovation

A new report from Finland’s Technical Research Center (VTT), “Recycling Food Packaging”, highlights those technology solutions expected to become commercially available in the next five years and says partnerships are essential to deliver the necessary technological innovations in food packaging recycling. VTT’s team examined current and near-future recycling systems for plastic and fiber packaging and found that alliances between brand owners, recycling and sorting technology developers, and waste management companies are fundamental to the development of recycling solutions. Such partnerships are essential for future investment in new recycling technology as they provide, on one hand, accessibility to used material, and on the other hand, a potential user for the recyclate. Commissioned by Huhtamaki the global sustainable packaging solutions provider, the report aims to identify and increase understanding of the key drivers required to deliver a functioning circular economy, in which importantly packaging is not only recyclable, but recycled. “The study predicts a significant increase in industrial chemical recycling capacity in the United States, Europe and East Asia in the next 3–4 years. Chemically recycled polymers can be included in food packaging after full depolymerization, whilst in practice today, recycled polymers certified as food contact material are mainly limited to rPET, used mostly in bottles”, says Mona Arnold, principal scientist at VTT.

Aptar Digital Health Acquires Healint to Broaden Neurology Portfolio

Aptar Digital Health, a global leader in digital health solutions (Software as a Medical Device (SaMD) and digital Patient Support Programs), connected devices and disease management, today announced that it has acquired Healint, a digital health company recognized for their virtual clinical studies, real-world evidence and patient registries platform, as well as the Migraine Buddy and Clarrio mobile apps, which support patients suffering from neurological and immunological conditions. The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment. The expanded capabilities include patient community management, patient activation, Artificial Intelligence (AI) based data collection and analysis, as well as digital diagnostics to facilitate patient screening and identification. Furthermore, Healint’s ability to conduct clinical studies at an accelerated pace and at a global scale complements Aptar Digital Health’s existing solutions to provide additional value to pharmaceutical customers.
Back To Top
×Close search
Search